Expanding on previously reported results in the overall population, new prespecified subgroup analyses showed greater Week 24 combined fistula remission with TREMFYA versus placebo among: 1 Perianal ...
Johnson & Johnson (NYSE: JNJ) today announced new three-year data from the Phase 3 GALAXI 2 and 3 studies showing durable ...
- Gilead GILD-0.55% Sciences' Yeztugo, a twice-yearly HIV prevention injection, drove 24% stock gains in 2026 with $232M Q2 revenue (annualized $1B+). - The long-acting PrEP drug faces internal ...
When Tennessee s execution of Christa Pike failed, she was rushed to the hospital for life-saving care, and the nation ...
In parallel with the fundraising, Ail Brescia - the note details - took on an operational role in the implementation of the intervention, accompanying the project from the design phase to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results